Search results

ISSUE NO. 6 — Hybrid Medicines and 505(b)(2) NDA Approval Pathways

Dec 1, 2018

• Regulatory Affairs
• End-to-End Program

Scientific Publication

Case Study—Driving Simulator Assessment

Dec 6, 2024

• Clinical Trials

ISSUE NO. 42 — Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development

Nov 1, 2024

• End-to-End Program
• Preclinical Research
• Clinical Trials
• Bioanalysis

Scientific Publication

Whole Genome Sequencing, Proteomics, and Function Characterization of the Sinclair Nanopig™ for (Bio)Pharmaceuticals Safety Assessment

Jul 23, 2024

• Preclinical Research

Scientific Publication

Collaborating for Success Tips for Improving Partnerships Between QA and Clinical Operations at Your Site

Apr 14, 2024

• CRO Services

Scientific Publication

Risk-Based Auditing and its Application to GLP Computerized System Validation Procedures

Apr 14, 2024

News

Life Science Review: Altasciences—Eliminating Operational Silos to Accelerate and Streamline Early-Phase Drug Development

Dec 29, 2023